Fluoxetine Mitigation Mental Health Study for Patients With Musculoskeletal Trauma
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
Musculoskeletal trauma is one of the leading causes of disability in the United States and
its negative quality of life impact extends beyond that of physical recovery. More than 50%
of victims of musculoskeletal trauma suffer lasting mental health issues following their
injury. These symptoms can develop across all spectrums of patients with a variety of injury
severities. Previously, this research team developed a ten-step program with the aim of
developing fostering coping mechanisms in trauma patients. We were unable to demonstrate a
measurable benefit to their mental health or physical function. This has been mirrored in
other studies as well; talk therapy and support groups are not a strong enough intervention
for some patients.
We hypothesize that a subset of the trauma population would benefit from medical treatment
for their depressive and anxious symptoms in the early recovery period. Given the limited
resources of mental health systems, it would be ideal for their surgical providers to be able
to manage safely their post-injury mental health issues during their surgical follow up. This
is a pragmatic pilot study to develop an effective, acceptable, time-limited treatment
strategy that could be safely implemented by non-mental health care providers for victims of
musculoskeletal trauma.